< Back to catalogue
Dapagliflozin
August 4, 2026Linagliptin + Metformin
August 4, 2026PHARMAZAC
Dapagliflozin + Metformin
Dapagliflozin/Metformin | Hypoglycemic | Business Development
| F.C. TABS (5+850)MG/TAB |
| F.C. TABS (5+1000)MG/TAB |
| F.C. TABS (5+850)MG/TAB |
| F.C. TABS (5+1000)MG/TAB |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | Under Development |
| THERAPEUTIC AREA |
